• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1011707-18
Device Problems Off-Label Use (1494); Difficult to Remove (1528); Material Separation (1562); Failure to Advance (2524)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/22/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported that the procedure was to treat a re-stenosed lesion located in the anterior tibial (at) artery that was heavily calcified and moderately tortuous.A xience prime stent delivery system (sds) was advanced over the wire to the target lesion in the at, but the sds would not cross the lesion and was manipulated on the wire back and forth.When the sds was removed from the patient, the proximal shaft snapped in half, outside the patient.The lesion was ballooned with an armada 14 and to complete the procedure.There were no reported adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported material separation was able to be confirmed.The reported failure to advance and the reported difficult to remove were unable to be replicated in a testing environment as they were based on operational circumstances.Additionally it was noted that there were multiple kinks on the outer member and bayonet/support wire, and the guide wire exit notch was torn.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that resistance was met with the heavily calcified and moderately tortuous anatomy resulting in the reported failure to advance and the reported difficult to remove.Manipulation of the device resulted in the noted device damages (multiple kinked outer member and bayonet/support wire, torn guide wire exit notch) and ultimately resulted in the reported material separation.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6; medical device problem code: 1494 - device was not used off label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11664619
MDR Text Key247685364
Report Number2024168-2021-03111
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/24/2023
Device Catalogue Number1011707-18
Device Lot Number0031841
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/15/2021
Initial Date Manufacturer Received 03/22/2021
Initial Date FDA Received04/14/2021
Supplement Dates Manufacturer Received05/18/2021
Supplement Dates FDA Received06/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-